UPDATE: H.C. Wainwright Double Downgrades Sio Gene Therapies (SIOX) to Sell, 'the company essentially now becomes a shell, in our belief'
Tweet Send to a Friend
(Updated - April 28, 2022 8:54 AM EDT)
H.C. Wainwright analyst Joseph Pantginis downgraded Sio Gene Therapies (NASDAQ: SIOX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Joseph Pantginis downgraded Sio Gene Therapies (NASDAQ: SIOX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
